Citi Starts Novavax (NVAX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq touch new peaks as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $11.29 -10.11%
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 17 | New: 35
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 17 | New: 35
Join SI Premium – FREE
Citi initiated coverage on Novavax (NASDAQ: NVAX) with a Buy rating and a price target of $9.00.
For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.
Shares of Novavax closed at $4.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lake Street Starts Rumble, Inc. (RUM) at Hold
- Melius Starts James Hardie Industries (JHX) at Buy
- Melius Starts Trex (TREX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
